𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Outcome of adults with acute lymphocytic leukemia after second salvage therapy

✍ Scribed by Susan O'Brien; Deborah Thomas; Farhad Ravandi; Stefan Faderl; Jorge Cortes; Gautum Borthakur; Sherry Pierce; Guillermo Garcia-Manero; Hagop M. Kantarjian

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
120 KB
Volume
113
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Liver function studies in children with
Liver function studies in children with acute lymphocytic leukemia after cessation of therapy
✍ Bessho, Fumio ;Kinumaki, Hiroshi ;Yokota, Shunichiro ;Hayashi, Yasuhide ;Kobayas πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 380 KB

## Abstract We investigated liver function in 27 children with acute lymphocytic leukemia (ALL) after cessation of therapy. Induction therapy consisted of prednisolone + vincristine (VP regimen) alone (16 patients) or with addition of daunorubicin (4 patients) or L‐asparaginase (7 patients). Patien

Defining the course and prognosis of adu
Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration
✍ Hagop M. Kantarjian; Deborah Thomas; Farhad Ravandi; Stefan Faderl; Elias Jabbou πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 173 KB

## Abstract ## BACKGROUND: Results from salvage therapy in adult patients with acute lymphocytic leukemia (ALL) are wide‐ranging and depend on several disease and patient characteristics. The objectives of this study were to define the prognosis for adult patients with ALL after first salvage thro

Primary refractory and relapsed adult ac
Primary refractory and relapsed adult acute lymphoblastic leukemia : Characteristics, treatment results, and prognosis with salvage therapy
✍ Deborah A. Thomas; Hagop Kantarjian; Terry L. Smith; Charles Koller; Jorge Corte πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 168 KB πŸ‘ 2 views

## BACKGROUND. Relapses continue to be problematic for adults with acute lymphoblastic leukemia (ALL). New therapies generally are first tested in the salvage setting prior to incorporation into frontline regimens. Defining the prognosis at relapse (or at failure of induction) and subsequently pre